Perceptive Advisors’s OncoMed Pharmaceuticals, Inc. OMED Stock Holding History

Perceptive Advisors’s Portfolio OMED Stock Details OMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-1,719,111	Closed	-$1.79M	–	128
2019 Q1	$1.79M	Hold	1,719,111	–	–	0.05%	78
2018 Q4	$1.28M	Sell	1,719,111 -901,786	-34%	-$1.36M	0.05%	78
2018 Q3	$5.56M	Hold	2,620,897	–	–	0.15%	68
2018 Q2	$6.05M	Hold	2,620,897	–	–	0.16%	69
2018 Q1	$8.33M	Hold	2,620,897	–	–	0.23%	65
2017 Q4	$10.7M	Buy	2,620,897 +1,582,608	+152%	+$6.89M	0.36%	51
2017 Q3	$4.69M	Buy	+1,038,289	New	+$4.21M	0.18%	71

Perceptive Advisors's OMED Position: Q2 2019 in Review

Perceptive Advisors sold out of OncoMed Pharmaceuticals, Inc. (OMED) in Q2 2019, closing a stake of 1,719,111 shares — an estimated $1.79M sold.

Perceptive Advisors first reported a position in OMED in Q3 2017 and held it in 7 quarters. The position peaked at $10.7M in Q4 2017. 0 funds tracked by Wall St. Rank hold OMED as of Q2 2019.

Perceptive Advisors reported no remaining OncoMed Pharmaceuticals, Inc. position as of Q2 2019 after selling out during the quarter.
Perceptive Advisors sold 1,719,111 OncoMed Pharmaceuticals, Inc. shares in Q2 2019, an estimated $1.79M.
Perceptive Advisors first reported a position in OncoMed Pharmaceuticals, Inc. in Q3 2017 and held it in 7 quarters.
Perceptive Advisors's OncoMed Pharmaceuticals, Inc. position peaked at $10.7M in Q4 2017.
0 funds tracked by Wall St. Rank held OncoMed Pharmaceuticals, Inc. as of Q2 2019.

Based on Perceptive Advisors's 13F filing for Q2 2019, filed 14 Aug 2019.